loadpatents
name:-0.020603895187378
name:-0.011544942855835
name:-0.0065460205078125
Lee; Sung-Hyung Patent Filings

Lee; Sung-Hyung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lee; Sung-Hyung.The latest application filed is for "heterodimeric antibodies that bind cd3 and tumor antigens".

Company Profile
6.11.18
  • Lee; Sung-Hyung - San Gabriel CA
  • LEE; Sung Hyung - Seoul KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
App 20220162343 - Bernett; Matthew J. ;   et al.
2022-05-26
Heterodimeric Antibodies That Bind Somatostatin Receptor 2
App 20220162313 - Moore; Gregory ;   et al.
2022-05-26
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
App 20220041757 - Bernett; Matthew J. ;   et al.
2022-02-10
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant 11,225,528 - Bernett , et al. January 18, 2
2022-01-18
Heterodimeric antibodies that bind somatostatin receptor 2
Grant 11,225,521 - Moore , et al. January 18, 2
2022-01-18
Semiconductor Device
App 20210375906 - KIM; Kang Min ;   et al.
2021-12-02
Semiconductor device
Grant 11,121,148 - Kim , et al. September 14, 2
2021-09-14
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant 11,111,315 - Bernett , et al. September 7, 2
2021-09-07
Semiconductor Device
App 20210202516 - KIM; Kang Min ;   et al.
2021-07-01
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
App 20210102003 - Bernett; Matthew J. ;   et al.
2021-04-08
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant 10,913,803 - Bernett , et al. February 9, 2
2021-02-09
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant 10,889,653 - Bernett , et al. January 12, 2
2021-01-12
Heterodimeric Antibodies That Bind Enpp3 And Cd3
App 20200317814 - Rashid; Rumana ;   et al.
2020-10-08
Trispecific Antibodies
App 20190352416 - Moore; Gregory ;   et al.
2019-11-21
Trispecific antibodies
Grant 10,428,155 - Moore , et al. October 1, 2
2019-10-01
Heterodimeric Antibodies That Bind Somatostatin Receptor 2
App 20190248898 - Moore; Gregory ;   et al.
2019-08-15
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
App 20190202938 - Bernett; Matthew J. ;   et al.
2019-07-04
Heterodimeric antibodies that bind somatostatin receptor 2
Grant 10,316,088 - Moore , et al.
2019-06-11
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant 10,259,887 - Bernett , et al.
2019-04-16
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
App 20180282432 - Bernett; Matthew J. ;   et al.
2018-10-04
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
App 20180223000 - Bernett; Matthew J. ;   et al.
2018-08-09
Heterodimeric Antibodies That Bind Somatostatin Receptor 2
App 20180118827 - Moore; Gregory ;   et al.
2018-05-03
Heterodimeric antibodies to CD3 X CD123
Grant 9,856,327 - Bernett , et al. January 2, 2
2018-01-02
Heterodimeric antibodies to CD3 X CD20
Grant 9,850,320 - Bernett , et al. December 26, 2
2017-12-26
Heterodimeric Antibodies To Cd3 X Cd123
App 20170081420 - Bernett; Matthew J. ;   et al.
2017-03-23
Heterodimeric Antibodies To Cd3 X Cd123
App 20170081424 - Bernett; Matthew J. ;   et al.
2017-03-23
Trispecific antibodies
App 20160355600 - Moore; Gregory ;   et al.
2016-12-08
Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
App 20160355608 - Bernett; Matthew J. ;   et al.
2016-12-08
Heterodimeric Antibodies Including Binding To Cd8
App 20160176969 - Bernett; Matthew J. ;   et al.
2016-06-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed